Microplate Reader Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

The Global Microplate Reader Market will grow from USD 495.77 Million in 2025 to USD 781.49 Million by 2031 at a 7.88% CAGR. These specialized laboratory instruments are essential for detecting and quantifying biological, chemical, or physical events within samples held in microtiter plates. The market is largely bolstered by the intensifying demand for high-throughput screening in drug discovery and the growing need for rapid diagnostic testing due to the prevalence of infectious diseases. Additionally, the sustained expansion of research activities within the pharmaceutical and biotechnology sectors serves as a core driver for market development, guaranteeing a consistent demand for effective sample analysis solutions.

Investment in scientific research serves as a key indicator of market potential. Data from the European Federation of Pharmaceutical Industries and Associations shows that the research-based pharmaceutical sector in Europe allocated an estimated €55.00 billion to R&D in 2024. This significant level of funding highlights a favorable environment for analytical instrumentation while also emphasizing the pressure to enhance efficiency in laboratory workflows. Despite these positive conditions, the market encounters a notable obstacle in the high acquisition costs of advanced multi-mode microplate readers, which may limit their adoption by smaller academic institutions and laboratories with restricted budgets.

Market Drivers

A primary propellant for the Global Microplate Reader Market is the escalating R&D expenditure by pharmaceutical and biotechnology companies. To revitalize drug pipelines and create new therapeutics, these organizations are directing substantial capital toward research initiatives that depend heavily on high-throughput screening technologies. This financial commitment is significant; a May 2024 report by Accountable US titled 'PhRMA Company R&D Spending' noted that eight major pharmaceutical firms collectively invested $95.9 billion in research and development during 2023. Such massive investment supports the purchase of sophisticated multi-mode readers, which are vital for speeding up drug discovery and boosting laboratory efficiency. This high-spending environment is producing tangible outcomes, as evidenced by BioPharm International's report in 2024 that the FDA approved 55 new drugs the previous year - the second-highest total in thirty years - underscoring the essential role of efficient screening tools in therapeutic development.

The rising incidence of chronic and infectious diseases further heightens the necessity for these detection platforms. As the global impact of conditions like cancer grows, laboratories are under increasing pressure to process diagnostic tests and research samples with greater speed and precision. The scale of this issue is considerable; the American Cancer Society's 'Cancer Facts & Figures 2024' report from January 2024 projected that new cancer cases in the United States would exceed 2 million for the first time in 2024. This surge in disease rates fuels a continuous demand for microplate readers, which are indispensable for quantifying biological markers in disease research and diagnostic workflows, thereby solidifying their importance in modern laboratory settings.

Market Challenges

The high cost of acquiring advanced multi-mode microplate readers represents a major barrier to the broader expansion of the Global Microplate Reader Market. Although these versatile instruments are crucial for modern high-throughput screening, their expensive pricing often surpasses the capital budgets of smaller laboratories and academic research centers. As a result, potential buyers with limited resources are compelled to extend the life of outdated equipment or settle for less capable single-mode devices. This lack of financial accessibility directly lowers sales volumes for premium units, leading to stagnant revenue growth in a key industry segment that relies on widespread technological adoption.

This difficulty is compounded by a reduction in external funding for scientific inquiry, which further diminishes purchasing power. The Association of American Universities reported in 2025 that final federal research funding decreased by 10.6% compared to 2023 levels, while the number of awards from the National Science Foundation fell by 50%. Such a sharp decline in available grants forces institutions to prioritize spending on operational consumables rather than capital investments. Consequently, the market is seeing a slowdown in procurement orders for high-end microplate readers, hindering the industry's capacity to capitalize on the scientific demand for advanced analytical capabilities.

Market Trends

The incorporation of Artificial Intelligence into automated data analysis is fundamentally transforming market dynamics by addressing the challenges of interpreting complex datasets. As microplate readers produce increasingly high-content data, laboratories are moving away from manual review in favor of software driven by machine learning algorithms that can identify patterns and predict experimental outcomes more rapidly. This technological evolution is supported by the Pistoia Alliance's 'Lab of the Future 2024 Global Survey' from September 2024, which indicates that 68% of life science professionals are now utilizing AI and machine learning, reflecting the shift of these technologies from experimental novelties to essential components of analytical workflows.

Simultaneously, the convergence of microplate reading with liquid handling automation is becoming more popular as institutions aim to reduce human error and maximize walk-away efficiency. Manufacturers are developing unified platforms that embed detection capabilities directly into liquid handling workstations, enabling continuous, high-throughput operations without the need for manual plate transfer. The demand for such integrated automated solutions remains strong despite market fluctuations; Tecan's 'Full Year 2023 Financial Results' report in March 2024 showed underlying sales growth of 6.3% in local currencies, confirming continued investment in automation technologies even amidst broader industry challenges.

Key Players Profiled in the Microplate Reader Market

• Danaher Corporation
• Thermo Fisher Scientific, Inc.
• BMG LABTECH GmbH
• PerkinElmer, Inc.
• Promega Corporation
• Bio-Rad Laboratories, Inc.
• Lonza Group Ltd.
• Agilent Technologies, Inc.
• Enzo Life Sciences, Inc.
• Berthold Technologies GmbH & Co. KG

Report Scope

In this report, the Global Microplate Reader Market has been segmented into the following categories:

Microplate Reader Market, by Product:

• Single Mode Readers
• Multi-Mode Readers

Microplate Reader Market, by Application Type:

• Genomics & Proteomics Research
• Drug Discovery
• Clinical Diagnostics
• Others

Microplate Reader Market, by End Use:

• Pharmaceutical & Biotechnology Companies & CROs
• Academic & Research Institutions
• Others

Microplate Reader Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Microplate Reader Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.